ACT Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.77M | Sell |
7,833
-500
| -6% | -$113K | 2.44% | 13 |
|
|
2022
Q2 | $1.58M | Hold |
8,333
| – | – | 2.2% | 11 |
|
|
2022
Q1 | $2.08M | Buy |
8,333
+3,050
| +58% | +$759K | 2.2% | 11 |
|
|
2021
Q4 | $823K | Hold |
5,283
| – | – | 0.6% | 32 |
|
|
2021
Q3 | $1.06M | Hold |
5,283
| – | – | 0.55% | 35 |
|
|
2021
Q2 | $1.35M | Buy |
+5,283
| New | +$1.35M | 0.69% | 32 |
|